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Abstract Polyphenolic antioxidants exhibited a dose-dependent
toxicity against human promyelocytic leukemia cells (HL-60).
Their action was accompanied by malondialdehyde formation,
and was partly prevented by desferrioxamine and the antioxidant
N,NP-diphenyl-p-phenylene diamine. This points to a prooxidant
character of their cytotoxicity. A quantitative structure-activity
relationship (QSAR) has been obtained to describe the
cytotoxicity of 13 polyphenolic antioxidants belonging to three
different groups (flavonoids, derivatives of gallic and caffeic
acid): log cL50 (WM) = (2.7829 þ 0.2339)+(1.2734 þ 0.4715) Ep=2
(V)3(0.3438 þ 0.0582) log P (r2 = 0.8129), where cL50 represents
the concentration for 50% cell survival, Ep=2 represents the
voltammetric midpoint potential, and P represents the octanol/
water partition coefficient. Analogous QSARs were obtained
using enthalpies of single-electron oxidation of these compounds,
obtained by quantum-mechanical calculations. These findings
clearly point to two important characteristics determining
polyphenol cytotoxicity, namely their ease of oxidation and their
lipophilicity.
z 1999 Federation of European Biochemical Societies.
Key words: Flavonoid; Polyphenol; Antioxidant;
Cytotoxicity; Oxidative stress
1. Introduction
Polyphenolic compounds (£avonoids, catechols, derivatives
of gallic acid) are widely distributed in edible plants, and
considered to be dietary antioxidants. The latter property is
derived from their free radical and activated oxygen scaveng-
ing activities [1]. Some of these compounds are currently used
as antioxidant food additives, e.g. esters of gallic acid [2].
The ability of polyphenols to protect cells from ‘oxidative
stress’ has been demonstrated [3,4]. In addition, these com-
pounds show a wide and contradictory spectrum of action,
involving antitumor, antiviral, antibacterial, cardioprotective,
pro- and antimutagenic activity [1,5^9]. The antiproliferative
e¡ects or apoptosis induced by £avonoids and other polyphe-
nols on several tumor cell lines were explained in terms of
topoisomerase [5] or phosphatidylinositol 3-kinase [6] inhibi-
tion, cell cycle arrest [7], accumulation of the tumor suppres-
sion protein p53 [8], or enhancement of expression of c-fos
and c-myc genes [9].
A possible, although insu⁄ciently investigated mechanism
of polyphenol cytotoxicity may be related to their prooxidant
properties, since the same polyphenol compounds could be-
have as both antioxidants and prooxidants, depending on
concentration and free radical source [10]. Flavonoids autox-
idize in aqueous medium, and may form highly reactive OH
radicals in the presence of transition metals [11]. Besides,
polyphenols and £avonoids may act as substrates for peroxi-
dases and other metalloenzymes, yielding quinone- or quino-
methide-type prooxidant and/or alkylating products [12^14].
The suggestion about the prooxidant character of polyphenol
cytotoxicity is supported by the formation of activated oxygen
species during gallic acid-induced apoptosis [15], and by the
enhancement of gallic and ca¡eic acid-induced apoptosis by
non-toxic concentrations of copper ions [16].
In this work, we have found that the toxicity of polyphe-
nolic oxidants belonging to three di¡erent groups (£avonoids
and derivatives of gallic and ca¡eic acid) towards human pro-
myelocytic leukemia cells (HL-60) is associated with the
prooxidant events. Further, we have established a quantitative
structure-activity relationship (QSAR), linking the polyphenol
cytotoxicity to their ease of oxidation (voltammetric midpoint
potential, enthalpy of single-electron oxidation), and lipophi-
licity.
2. Materials and methods
2.1. Materials
Flavonoids, gallic acid and its esters, ca¡eic and chlorogenic acid,
desferrioxamine and N,NP-diphenyl-p-phenylene diamine (DPPD)
were obtained from Sigma or Aldrich, and used as received.
2.2. Cytotoxicity studies
HL-60, human promyelocytic leukemia cells, obtained from Amer-
ican Type Culture Collection (ATCC, Rockville, MD, USA), were
cultured in RPMI 1640 medium supplemented with 10% fetal calf
serum, 1% glutamine, 100 U/ml penicillin, 100 Wg/ml streptomycin,
and incubated in a humidi¢ed atmosphere with 5% CO2 at 37‡C. Cells
were passaged every 4 days. In cytotoxicity experiments, 2 ml cell
suspension (1.0U105/ml) was incubated in the presence of various
concentrations of polyphenols for 24 h. The cell viability was deter-
mined by an automated bioluminescent assay for cellular ATP [17],
and expressed as the ratio of the ATP content in polyphenol-exposed
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to unexposed cells. The stock solutions of polyphenols were prepared
in dimethylsulfoxide (DMSO). The concentration of DMSO in cul-
tivation media did not exceed 0.2%, and did not a¡ect the cell via-
bility.
The lipid peroxidation in the cells was monitored by detecting the
formation of malondialdehyde, using the thiobarbituric acid test [18].
Brie£y, cells were washed by cold physiological saline and disrupted
by sonication. To the disrupted cells (1.4 ml) was added 0.2 ml of 10%
trichloroacetic acid and 0.4 ml 0.6 M thiobarbituric acid, and tubes
were heated in boiled water. Upon cooling and subsequent centrifu-
gation (8000 rpm, 20 min), the absorbance of supernatant was read at
532 nm by a Hitachi 557 spectrophotometer, and the amount of
malondialdehyde was calculated using vO= 156 mM31 cm31.
2.3. Cyclic voltammetry studies of polyphenols
Cyclic voltammograms of quercetin and derivatives of gallic acid
were recorded with a PA-2 polarograph provided with 4103 X-Y
recorder (Laboratorni Pristroje, Czech Republic), in 0.1 M K-phos-
phate (pH 7.0) containing 1 mM EDTA, at 25‡C under anaerobic
conditions. A glassy carbon SU-1500 electrode served as a working
electrode, a saturated calomel electrode (SCE, +244 mV vs. NHE) was
used as the reference, and a platinum electrode (surface area 56 mm2)
was used as an auxiliary electrode. The cyclic voltammograms were
recorded at potential scan rate 100 mV s31 as described previously
[13]. The voltammetric midpoint potentials (Ep=2) were calculated
from anodic (Epa) and cathodic (Epc) peak potentials,
Ep=2 = (Epa+Epc)/2, for the reversible and quasi-reversible processes.
For irreversible systems characterized by the absence of cathodic
peak potentials, Ep=2 was determined as a potential where current is
half the anodic peak current [13].
2.4. Quantum-mechanical and partition coe⁄cient calculation,
statistical analysis
Semiempirical PM3, ab initio HF/3-21G* and density functional
theory (DFT) B3LYP/6-311G** calculations on compounds studied
in this work were carried out with the use of the GAUSSIAN 94
package (Gaussian Inc., Pittsburgh, PA, USA). Calculations were
performed on polyphenols and the single- and two-electron oxidized
forms of these polyphenols speci¢ed below. In all cases the geometry
was optimized with respect to all degrees of freedom. The PM3 opti-
mized geometries of the species studied served both to calculate PM3
thermochemical data and as starting geometries for the ab initio HF/
3-21G* optimization. The HF/3-21G* optimized geometries were then
used for higher level DFT B3LYP/6-311G** single-point calculations.
The enthalpies of reactions (vHf) were calculated using the Hess law
from Eqs. 1^3, where QH2 denotes polyphenol, QH or Q3 denote
its single-electron oxidized forms, Q denotes its two-electron oxidized
form, and Hf denotes the heat of formation:
2H; 1e3 transfer : vHf1  HfQ33HfQH2; 1
1H; 1e3 transfer : vHf2  HfQH3HfQH2; 2
2H; 2e3 transfer : vHf3  HfQ3HfQH2: 3
The octanol/water partition coe⁄cients (P) for £avonoids and other
polyphenols were calculated using an ACD logP (version 1) software,
a generous gift of Advanced Chemistry Development Inc. (Toronto,
Ont., Canada). The multiparameter regression analysis was performed
using Statistica (version 4.3) software (StatSoft Inc., 1993).
3. Results
The presence of £avonoids and other polyphenols in growth
media caused concentration-dependent decreases in cell viabil-
ity. The concentrations of compounds for 50% decreasing cell
viability (cL50) are given in Table 1. The action of polyphenols
was accompanied by prooxidant events, since several polyphe-
nols at concentrations corresponding to 80^90% decrease in
cell viability (300 WM quercetin, 800 WM taxifolin or 250 WM
butylgallate) stimulated lipid peroxidation. Typically, malon-
dialdehyde concentration increased from 0.3 þ 0.1 nmol/106
cells in control, to 1.0 þ 0.28 nmol/106 cells. Second, the tox-
icity of taxifolin to HL-60 cells was markedly prevented by
the antioxidant DPPD [19] and the iron chelator desferriox-
amine, the latter preventing the Fenton reaction (Fig. 1).
Analogous e¡ects of DPPD and desferrioxamine were ob-
served for quercetin and butylgallate toxicity as well (data
not shown). Another characteristic of polyphenol action is
that their cytotoxicity increases upon an increase in their lip-
ophilicity (octanol/water partition coe⁄cient, P), which is
most clearly evidenced by comparison of a series of gallic
acid derivatives (Fig. 2, Table 1). This ¢nding closely resem-
bles the previously observed order of e⁄ciency of gallic acid
derivatives in preventing proliferation of the mouse B cell
lymphoma cells [20].
Since the cytotoxicity of polyphenols to HL-60 cells is at
least partly related to prooxidant events, it is of interest to
examine the dependence of cytotoxicity on the energetics of
single- and two-electron oxidation of polyphenols. In order to
describe QSARs, we have compiled the available values of
single-electron oxidation potentials (E1) for £avonoids and
polyphenols determined by pulse radiolysis [21,22] (Table 1).
Table 1
The concentrations of polyphenols for 50% survival of HL-60 cells (cL50), the potentials of their single-electron oxidation (E17), voltammetric
midpoint potentials (Ep=2), and their octanol/water partition coe⁄cients (P)
Number Compound cL50 (WM) E17 (V) Ep=2 (V) log P
1 Quercetin 100 þ 30 0.60a 0.29c;d 2.74
2 Morin 250 þ 40 0.95a 0.34c 1.97
3 Kaempferol 125 þ 20 0.95a 0.39c 2.69
4 Taxifolin 600 þ 150 0.37c;e 1.22
5 Hesperetin 500 þ 100 0.72a 0.59c;e 2.3
6 Naringenin 700 þ 100 0.76c;e 2.59
7 Gallic acid 750 þ 200 0.29d;e 0.91
8 Methylgallate 400 þ 100 0.56b 0.28d;e 1.54
9 Ethylgallate 160 þ 40 0.28d;e 2.07
10 Butylgallate 110 þ 30 0.28d;e 3.13
11 Octylgallate 30 þ 10 0.27d;e 5.26
12 Ca¡eic acid 800 þ 150 0.54b 0.36c 2.47
13 Chlorogenic acid v 2000 0.37c 0.69
avs. normal hydrogen electrode (NHE), pH 7.0 [21].
bvs. NHE, pH 7.0 [22].
cvs. NHE, pH 7.4 [13].
dvs. NHE, pH 7.4, present work.
eIrreversible.
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Next, we have determined the previously unknown voltam-
metric midpoint potentials (Ep=2) for several compounds in-
vestigated. Their values are given in Table 1 together with
Ep=2 for other polyphenols taken from [13]. Finally, we have
performed quantum-mechanical calculations of enthalpies of
polyphenol oxidation (vHf). The calculated values of vHf
increases upon increase in E1 [22], and may serve as an alter-
native parameter to describe QSARs. The calculated values of
vHf for various single- and two-electron oxidation products
of £avonoids and polyphenols are given in Table 2. One
should note that among several possible products of querce-
tin, morin and kaempferol oxidation, their p-quinomethide
isomers (Fig. 3), characterized by the lowest values of vHf,
were used for analysis.
4. Discussion
The data of the present study, pointing to a prooxidant
character of polyphenol cytotoxicity, are consistent with pre-
vious ¢ndings on the involvement of activated oxygen species
in gallic and ca¡eic acid-induced apoptosis [15,16]. One may
expect that the cytotoxicity of polyphenols, if related to ‘oxi-
dative stress’, may increase upon decrease in the potential of
their single-electron oxidation (E1), i.e. the potential of semi-
quinone/catechol (or phenoxy radical/phenol) redox couple.
For example, low-potential catechols or phenols will more
rapidly autoxidize or be oxidized by hemoproteins [23], reduce
transition metals or reductively mobilize iron from ferritin
[24]. This approach is based on the analogy with prooxidant
cytotoxicity of quinones and nitroaromatic compounds, which
increases upon increase in their single-electron reduction po-
tential [27,28], i.e. the rate of their single-electron enzymatic
reduction initiating ‘redox cycling’ [26^28].
The analysis of data of Tables 1 and 2 reveals the absence
of the correlations between polyphenol log cL50 and the E1, or
Ep=2, or vHf1ÿ3 of the polyphenols, since r2 varies in the range
0.0254^0.2011. The increase of cytotoxicity of gallic acid de-
rivatives upon an increase in their lipophilicity (Fig. 2)
prompted us to introduce log P as the second parameter for
the correlation studies. Further, it was assumed that E1 for
the derivatives of gallic acid (compounds 7^11, Table 1) is
equal to 0.56 V, and that E1 for chlorogenic acid is equal to
0.54 V, as for ca¡eic acid. The resulting Eq. 4 was character-
Fig. 1. The protective e¡ects of DPPD (2.5 WM) and desferriox-
amine (300 WM) against toxicity of 800 WM taxifolin to HL-60 cells.
Additions: taxifolin (1), taxifolin+DPPD (2), taxifolin+desferriox-
amine (3), taxifolin+DPPD+desferrioxamine (4), n = 4, P6 0.05 for
2^4 against 1. In the absence of £avonoid, DPPD and desferriox-
amine did not a¡ect cell viability.
Fig. 2. The dependence of the toxicity of gallic acid derivatives to
HL-60 cells on their octanol/water partition coe⁄cient (P) : gallic
acid (1), methylgallate (2), ethylgallate (3), butylgallate (4), and oc-
tylgallate (5), n = 4, concentration of each compound, 125 WM.
Table 2
Enthalpies of reaction of single-electron oxidation (vHf1 and vHf2) and two-electron oxidation (vHf3) of £avonoids and polyphenols, calcu-
lated using DFT B3LYP/6-311G**//HF//3-21G* method. vHf1ÿ3 were obtained from Eqs. 1^3, and correspond to the formation of o-semiqui-
none or o-quinone products, unless speci¢ed otherwise.
Number Compound vHf1 (kcal/mol) (32H, 3e3) vHf2 (kcal/mol) (3H, 3e3) vHf3 (kcal/mol) (32H, 32e3)
1 Quercetina 407.3 81.4 155.4
2 Morina 408.9 83.9 164.7
3 Kaempferola 414.4 88.4 162.5
4 Taxifolin 425.0 82.3 158.3
5 Hesperetin 429.5 89.6 ^
6 Naringenin 425.0 90.8 ^
7 Gallic acid 414.9 78.9 157.0
8 Methylgallate 416.2 78.3 156.4
9 Ethylgallate 416.2 78.2 156.2
10 Butylgallate 416.3 77.9 155.8
11 Octylgallate 416.2 78.2 156.2
12 Ca¡eic acid 417.6 81.2 160.5
13 Chlorogenic acid 418.8 80.8 160.0
ap-Quinomethide products (Fig. 3).
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ized by r2 = 0.7590, however, the dependence of log cL50 on E1
was relatively scattered:
log cL50 WM  3:574 0:410930:4781 0:5669 E1 V
30:3618 0:0733 log P 4
In our understanding, this might be attributed to the evidently
overestimated values of E1 for morin and kaempferol (Table
1), calculated from the pulse radiolysis data [22]. Evidently,
the pulse radiolysis data for morin, kaempferol and hesperetin
are in marked contrast to their electrochemical characteristics,
i.e. Ep=2 values and reversibility (Table 1).
Alternatively, we may observe a correlation between cyto-
toxicity, Ep=2 and log P, clearly pointing to an increase in
cytotoxicity upon increase in ease of electrochemical oxidation
of polyphenols, and their lipophilicity (Fig. 4):
log cL50 WM  2:7829 0:2339  1:2734 0:4715 Ep=2 V
30:3438 0:0582 log P r2  0:8129 5
Although in general, the increase in Ep=2 parallels the in-
crease in E1, the Ep=2 values are not entirely adequate substi-
tutes for E1 : (i) in reversible or quasi-reversible cyclic voltam-
mograms where both Epa and Epc are present (corresponding
to oxidation of polyphenols, and to re-reduction of quinone
or quinomethide products, respectively), Ep=2 de¢nes the en-
ergetics of a net two-electron transfer [13] ; (ii) the irreversible
electrooxidation characterized by the absence of Epc (isomer-
ization of oxidation products into electroinactive species) may
proceed at certain overvoltage, and Ep=2 (Table 1) may not
represent the reversible redox potential described by the
Nernst equation. On the other hand, the enthalpy of single-
electron oxidation of polyphenols increases upon increase in
E1 [22]. For these reasons, we have used additional evidence
for QSAR between the cytotoxicity and ease of (electro)oxi-
dation of polyphenols, obtaining analogous correlations (Eqs.
6 and 7) between log cL50, log P and calculated enthalpies of
single-electron oxidation of polyphenols (vHf1 and vHf2, Ta-
ble 2) (data not shown):
log cL50 WM  38:5079 4:8178  0:0281 0:0115W
vHf 1 kcal=mol30:3310 0:0609 log P r2  0:7977;
6
log cL50 WM  1:2965 1:4946  0:0234 0:0179W
vHf 2 kcal=mol30:3483 0:07045 log P r2  0:7254;
7
On the other hand, in the analogous two-parameter Eq. 8, the
dependence of log cL50 on vHf3 was relatively scattered:
log cL50 WM  0:3445 4:594  0:0181 0:0288W
vHf 3 kcal=mol30:3510 0:0695 log P r2  0:7816:
8
Our ¢ndings imply that although prooxidant events are
important in polyphenol cytotoxicity to HL-60 cells, it does
not depend entirely on their thermodynamic parameters, and
that an increase in polyphenol lipophilicity may also increase
their cytotoxicity. Evidently, the polyphenols have to pass the
cell membrane and enter the cell before exerting their toxic
e¡ects. This may be supported by the fact that irrespective of
the thermodynamical parameter used (Ep=2, Hf1 or Hf2), the
proportionality coe⁄cient vlog cL50/vlog P varies insigni¢-
cantly, in the range 30.33 to 30.35 (Eqs. 5^8). The toxicity
of polyphenols is relatively insensitive to their redox potential,
since the coe⁄cient vlog cL50/vEp=2 (Eq. 5) is close to 1.3
V31, whereas for redox cycling quinones and aromatic nitro
Fig. 3. Structures of two-electron oxidation products of quercetin,
morin and kaempferol.
Fig. 4. The dependence of polyphenol cytotoxicity on their voltam-
metric midpoint potential (Ep=2) and octanol/water partition coe⁄-
cient (P) according to a multiparameter Eq. 5. The numbers of
compounds are taken from Table 1.
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compounds, this coe⁄cient is close to 310 V31 [25^27]. Prob-
ably, other modes of polyphenol action may contribute to
their toxicity as well. Nevertheless, our data provide a diag-
nostic tool for prediction of cytotoxicity of polyphenolic com-
pounds. This is especially important in relation to increased
toxicity of certain polyphenols, e.g. epigallocatechin gallate [9]
or derivatives of gallic acid [20] to malignant and transformed
cells as compared to their normal counterparts. Interestingly,
cell malignization or transformation is often accompanied by
a decrease in activity of antioxidant enzymes (superoxide dis-
mutase, catalase, glutathione peroxidase) [29], which increases
the cell sensitivity to prooxidant compounds [29,30]. On the
other hand, the use of polyphenolic compounds may represent
a novel approach in the treatment of anthracycline-resistant
acute myelogenous leukemia [17,31]. Our preliminary studies
of a previously established anthracycline-resistant HL-60 cell
line [17] indicate that it retains almost the same sensitivity to
polyphenolic compounds (quercetin, cL50 = 50 þ 10 WM; mor-
in, cL50 = 280 þ 50 WM; ca¡eic acid, cL50 = 890 þ 150WM) as its
anthracycline-sensitive counterpart (Table 1).
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